14-3-3η protein ameliorates glomerular endothelial cell injury in lupus nephritis by regulating mTOR pathway-mediated autophagy
European Journal of Pharmacology · 2026-07 · 1029 · 178983
DOI: 10.1016/j.ejphar.2026.178983 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2026-07. Verfasst von Xinghui Song und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, 545005, China. Electronic address: …. Hauptthemen laut MEDLINE: Lupus Nephritis, Autophagy, TOR Serine-Threonine Kinases, 14-3-3 Proteins. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Natural Science Foundation of Guangxi Province.
Abstract (Originalsprache)
BACKGROUND Lupus nephritis (LN), a severe complication of systemic lupus erythematosus (SLE), is characterized by glomerular endothelial cell injury, inflammation, and immune complex deposition. The 14-3-3η protein, a multifunctional regulator, plays roles in various cellular processes, however, its specific role in LN and the underlying mechanisms remain unclear. This study investigates the role of 14-3-3η in LN by modulating mTOR pathway-mediated autophagy. METHODS Human renal glomerular endothelial cells (HRGECs) overexpressing 14-3-3η were treated with plasma from healthy donors and LN patients. Cell viability, nitric oxide (NO) levels, and the expression of syndecan-1, VCAM-1, 14-3-3η, and autophagy markers (LC3, PINK1, Parkin) were analyzed. In vivo, an LN mouse model was established, and treated with 14-3-3η-overexpressing adenovirus or rapamycin (RAP) was administered. Renal histopathology, serum syndecan-1, VCAM-1, and autophagy markers were evaluated. RESULTS In vitro, 14-3-3η overexpression attenuated LN plasma-induced endothelial injury, enhanced cell viability, reduced NO levels, and downregulated syndecan-1 and VCAM-1 expression. It also suppressed autophagy by promoting mTORC1 complex formation and downstream signaling via mTOR S1276 phosphorylation. In vivo, 14-3-3η overexpression ameliorated glomerular pathology and inhibited autophagy by regulating mTOR, LC3, PINK1, and Parkin. CONCLUSION 14-3-3η alleviates LN-induced glomerular endothelial injury and renal dysfunction by modulating mTOR-mediated autophagy. This study identifies 14-3-3η as a potential therapeutic target for LN and advances the understanding of its role in kidney diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, 545005, China. Electronic address: Lzhuihui3012@163.com.
- Department of Rheumatology and Immunology, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, 545005, China.
Förderung
- Natural Science Foundation of Guangxi Province
Zitieren
APA
Song, X., Tang, K., Gao, J., Liu, X., Jiang, Q., & Ma, L. (2026). 14-3-3η protein ameliorates glomerular endothelial cell injury in lupus nephritis by regulating mTOR pathway-mediated autophagy. European Journal of Pharmacology, 1029, 178983. https://doi.org/10.1016/j.ejphar.2026.178983
Vancouver
Song X, Tang K, Gao J, Liu X, Jiang Q, Ma L. 14-3-3η protein ameliorates glomerular endothelial cell injury in lupus nephritis by regulating mTOR pathway-mediated autophagy. European Journal of Pharmacology. 2026;1029:178983. doi:10.1016/j.ejphar.2026.178983
BibTeX
@article{Song2026,
author = {Song, Xinghui and Tang, Kaijiang and Gao, Jinglin and Liu, Xiuhua and Jiang, Qijun and Ma, Li},
title = {14-3-3η protein ameliorates glomerular endothelial cell injury in lupus nephritis by regulating mTOR pathway-mediated autophagy},
journal = {European Journal of Pharmacology},
year = {2026},
volume = {1029},
pages = {178983},
doi = {10.1016/j.ejphar.2026.178983}
}
EUVIMED